Schizophrenia is a severe behavioral syndrome of neurodevelopmental nature marked by
primary or genuine motor abnormalities (GMA), which refer to spontaneous and medication …

Tardive dyskinesia (TD) is a serious and potentially irreversible side effect of long-term
exposure to antipsychotic medication characterized by involuntary trunk, limb and orofacial …

Regarding weight gain, most promising and most consistent findings were obtained in the
serotonergic system (HTR2C) and with hypothalamic leptin–melanocortin genes, in …

We provide an overview of the recent achievements in psychiatric genetics research in the
Russian Federation and present genotype-phenotype, population, epigenetic, cytogenetic …

Identifying biomarkers which can be used as a diagnostic tool is a major objective of
pharmacogenetic studies. Most mental and many neurological disorders have a compiled …

Objectives. The aim of this study was to investigate a possible association between tardive
dyskinesia (TD) and CYP1A2 (* 1F,-163C> А, rs762551) polymorphism in Russian …

Tardive dyskinesia is a severe motor adverse event of antipsychotic medication,
characterized by involuntary athetoid movements of the trunk, limbs, and/or orofacial areas …

В предлагаемой вниманию читательской аудитории монографии освещены
современные гипотезы участия фармакогенетических факторов в патогенезе …

Tardive dyskinesia (TD) is a serious motor side effect that may appear after long-term
treatment with neuroleptics and mostly mediated by dopamine D2 receptors (D2Rs). Striatal …

В монографии освещены современные представления о концепции тардивной
дискинезии, представлены результаты собственных исследований тардивной …